Posted On: 10/11/2015 11:43:27 AM
Post# of 30066
Oct 1 - Slide 28 - Deriving full value from neuro-diagnostics business through potential sale, co-development or spinoff opportunities
Oct 9 - Slide 38 - Deriving full value from neuro-diagnostics business through potential strategic transactions
Oct 1 - Slide 27 - Dx Key Takeaways & Upcoming Milestones
Oct 9 - Dropped
Oct 9 - 34:12 - "We are getting ready for some strategic transactions in the diagnostic space"
Oct 9 - 34:55 - "We have our Neuro-Diagnostics subsidiary where we already have significant human proof of concept and we are now looking to commercialize those through strategic transaction.
Oct 9 - Slide 38 - Deriving full value from neuro-diagnostics business through potential strategic transactions
Oct 1 - Slide 27 - Dx Key Takeaways & Upcoming Milestones
Oct 9 - Dropped
Oct 9 - 34:12 - "We are getting ready for some strategic transactions in the diagnostic space"
Oct 9 - 34:55 - "We have our Neuro-Diagnostics subsidiary where we already have significant human proof of concept and we are now looking to commercialize those through strategic transaction.
(0)
(0)
